Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

High dose of trimethoprim-sulfamethoxazole and daptomycin as a therapeutic option for MRSA endocarditis with large vegetation complicated by embolic stroke: a case report and literature review.

Di Carlo P, D'Alessandro N, Guadagnino G, Bonura C, Mammina C, Lunetta M, Novo S, Giarratano A.

Infez Med. 2013 Mar;21(1):45-9. Review.

2.

Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.

Campbell ML, Marchaim D, Pogue JM, Sunkara B, Bheemreddy S, Bathina P, Pulluru H, Chugh N, Wilson MN, Moshos J, Ku K, Hayakawa K, Martin ET, Lephart PR, Rybak MJ, Kaye KS.

Ann Pharmacother. 2012 Dec;46(12):1587-97. doi: 10.1345/aph.1R211. Epub 2012 Dec 4.

PMID:
23212935
4.
5.

High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis.

Miró JM, Entenza JM, Del Río A, Velasco M, Castañeda X, Garcia de la Mària C, Giddey M, Armero Y, Pericàs JM, Cervera C, Mestres CA, Almela M, Falces C, Marco F, Moreillon P, Moreno A; Hospital Clinic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2012 Aug;56(8):4511-5. Epub 2012 May 29.

8.

Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.

Claeys KC, Smith JR, Casapao AM, Mynatt RP, Avery L, Shroff A, Yamamura D, Davis SL, Rybak MJ.

Antimicrob Agents Chemother. 2015 Apr;59(4):1969-76. doi: 10.1128/AAC.04141-14. Epub 2015 Jan 20.

9.

In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis.

Dortet L, Anguel N, Fortineau N, Richard C, Nordmann P.

Int J Infect Dis. 2013 Nov;17(11):e1076-7. doi: 10.1016/j.ijid.2013.02.019. Epub 2013 Apr 9.

10.

Daptomycin resistance and treatment failure following vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE).

Cunha BA, Pherez FM.

Eur J Clin Microbiol Infect Dis. 2009 Jul;28(7):831-3. doi: 10.1007/s10096-008-0692-2. Epub 2009 Jan 28.

PMID:
19184141
11.

Methicillin-resistant Staphylococcus aureus infection with intermediate sensitivity to vancomycin: a case report and literature review.

Schairer J, Sankri-Tarbichi AG, Fairfax MR, Salimnia H, Guzman JA.

J Intensive Care Med. 2008 Sep-Oct;23(5):338-41. doi: 10.1177/0885066608320849. Review.

PMID:
18701528
12.

[Treatment of mitral MRSA endocarditis using daptomycin].

Senneville E, Beltrand E, Legout L, Leroy O, Fayad G.

Med Mal Infect. 2008 Dec;38 Spec No 2:13-5. doi: 10.1016/S0399-077X(08)75154-0. French. No abstract available.

PMID:
19185204
13.

In vivo development of heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA), GISA and daptomycin resistance in a patient with meticillin-resistant S. aureus endocarditis.

Kirby A, Mohandas K, Broughton C, Neal TJ, Smith GW, Pai P, Nistal de Paz C.

J Med Microbiol. 2009 Mar;58(Pt 3):376-80. doi: 10.1099/jmm.0.006486-0.

PMID:
19208891
14.

Novel daptomycin combinations against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.

Steed ME, Vidaillac C, Rybak MJ.

Antimicrob Agents Chemother. 2010 Dec;54(12):5187-92. doi: 10.1128/AAC.00536-10. Epub 2010 Oct 4.

15.

[Treatment of multiresistant Gram positive endocarditis].

Utili R.

Infez Med. 2009 Jul;17 Suppl 3:13-24. Italian.

16.

Staphylococcus aureus bloodstream infections: definitions and treatment.

Corey GR.

Clin Infect Dis. 2009 May 15;48 Suppl 4:S254-9. doi: 10.1086/598186. Review.

PMID:
19374581
17.

Daptomycin use after vancomycin-induced neutropenia in a patient with left-sided endocarditis.

Mergenhagen KA, Pasko MT.

Ann Pharmacother. 2007 Sep;41(9):1531-5. Epub 2007 Jul 24.

PMID:
17652126
18.

Treatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid.

Corne P, Marchandin H, Macia JC, Jonquet O.

Scand J Infect Dis. 2005;37(11-12):946-9.

PMID:
16308242
20.

Daptomycin is effective in treatment of experimental endocarditis due to methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

Marco F, de la Mària CG, Armero Y, Amat E, Soy D, Moreno A, del Río A, Almela M, Mestres CA, Gatell JM, Jiménez de Anta MT, Miró JM; Hospital Clinic Experimental Endocarditis Study Group.

Antimicrob Agents Chemother. 2008 Jul;52(7):2538-43. doi: 10.1128/AAC.00510-07. Epub 2008 Apr 21.

Supplemental Content

Support Center